Dengue Fever: Etiology, Diagnosis, Prevention and Treatment
暂无分享,去创建一个
[1] D. Dwyer,et al. Arthropod-Borne Flaviviruses in Pregnancy , 2023, Microorganisms.
[2] B. Gessner,et al. Updated recommendations of the International Dengue Initiative expert group for CYD-TDV vaccine implementation in Latin America. , 2019, Vaccine.
[3] K. Uddin. Dengue in 2019 , 2019, BIRDEM Medical Journal.
[4] First FDA-approved vaccine for the prevention of dengue disease in endemic regions , 2019, Case Medical Research.
[5] J. Walley,et al. A cross-sectional survey on the seroprevalence of dengue fever in febrile patients attending health facilities in Cross River State, Nigeria , 2019, PloS one.
[6] G. Nchinda,et al. Seroprevalence of dengue virus among children with febrile illness in Nnewi, Nigeria , 2018 .
[7] J. Mustapha,et al. Survey of malaria and anti-dengue virus IgG among febrile HIV-infected patients attending a tertiary hospital in Abuja, Nigeria , 2017, HIV/AIDS.
[8] J. Stanaway,et al. The global economic burden of dengue: a systematic analysis. , 2016, The Lancet. Infectious diseases.
[9] D. Musso,et al. Rapid spread of emerging Zika virus in the Pacific area. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[10] S. Yacoub,et al. Predicting outcome from dengue , 2014, BMC Medicine.
[11] Dennis Normile,et al. Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. , 2013, Science.
[12] E. Undurraga,et al. Economic and Disease Burden of Dengue in Southeast Asia , 2013, PLoS neglected tropical diseases.
[13] Motayo Babatunde Olanrewaju,et al. SEROLOGICAL EVIDENCE OF RECENT DENGUE VIRUS INFECTION AMONG FEBRILE CHILDREN IN A SEMI ARID ZONE , 2013 .
[14] B. Guy,et al. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. , 2011, Vaccine.
[15] H. Margolis,et al. Dengue Virus Infection in Africa , 2011, Emerging infectious diseases.
[16] Niranjan Kissoon,et al. Dengue hemorrhagic fever and shock syndromes* , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[17] Rosanna W. Peeling,et al. Dengue: a continuing global threat , 2010, Nature Reviews Microbiology.
[18] Mary E. Wilson,et al. Dengue and chikungunya infections in travelers , 2010, Current opinion in infectious diseases.
[19] V. Wiwanitkit. Dengue fever: diagnosis and treatment , 2010, Expert review of anti-infective therapy.
[20] A. Varatharaj. Encephalitis in the clinical spectrum of dengue infection. , 2010, Neurology India.
[21] J. Smit,et al. Dengue virus life cycle: viral and host factors modulating infectivity , 2010, Cellular and Molecular Life Sciences.
[22] P. Reiter,et al. Yellow fever and dengue: a threat to Europe? , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[23] J. Rey. What is Dengue? , 2007, EDIS.
[24] L. Wilkins. Part 12: Pediatric Advanced Life Support , 2005 .
[25] A. Kahng,et al. International , 1964, PS: Political Science & Politics.
[26] S. Halstead,et al. Dengue , 1872, The Lancet.
[27] N. Idrisa. Sero-prevalence of dengue type-3 Virus among patients with febrile illnesses attending a tertiary hospital in Maiduguri , Nigeria , 2013 .
[28] M. Talle. The Effect of Climate on Dengue Virus Infections in Nigeria , 2011 .
[29] E. Konishi. [Dengue vaccine]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[30] Healthgrid Applications and Core Technologies - Proceedings of HealthGrid 2010, University Paris XI, Orsay, Paris, France, June 28-30, 2010 , 2010, HealthGrid.
[31] M. V. Regenmortel,et al. Desk Encyclopedia of Human and Medical Virology , 2010 .
[32] R. Schlesinger,et al. Dengue Viruses , 1977, Virology Monographs Die Virusforschung in Einzeldarstellungen.